Clinical Trial

LUNG INFECTION in ICU (LUNG-I3)

Study acronym: LUNG-I3
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 12, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
objective of LUNG-I3 study is to assess the quantitative and functional differences in cells between blood and bronchoalveolar lavage (BAL) fluid after an infection, with a special focus on alveolar macrophages and neutrophils
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-03.
Status change: Not Yet Recruiting → Recruiting 2025-02-10
Trial Details
NCT Number NCT06073834
Lead Sponsor BioMérieux
Conditions VAP - Ventilator Associated Pneumonia
Enrollment 68 participants
Start Date 2023-12-05
Primary Completion 2026-04 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-02-12